Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000041

EVP, Chief Strat & Dev Officer gave up 764 shares (to pay taxes)

  • EVP, Chief Strat & Dev Officer acquired 48,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SARAN ATUL EVP, Chief Strat & Dev Officer 2022-03-01 Grant or award +31,417 74,630 D: show line 1 in the form
SARAN ATUL EVP, Chief Strat & Dev Officer 2022-03-01 Grant or award +16,916 91,546 D: show line 2 in the form
SARAN ATUL EVP, Chief Strat & Dev Officer 2022-02-28 Shares withheld for taxes −764 $39.64 $30,285 90,782 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SARAN ATUL EVP, Chief Strat & Dev Officer 2022-03-01 Grant or award · Employee Stock Options (Right to Buy) +38,664 $41.38 $1,599,916 38,664 D: show line 4 in the form
Loading xslF345X03/wf-form4_164626470277626.xml…